Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Boston Scientific to Participate in 38th Annual Canaccord Genuity Growth Conference

Boston Scientific
Posted on: 31 Jul 18

MARLBOROUGH, Mass., July 30, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 38th Annual Canaccord Genuity Growth Conference on Wednesday, August 8, 2018 in Boston.

Susie Lisa, vice president, Investor Relations, and Lindsay Fish, director, Investor Relations, will participate in a 25-minute question-and-answer session with the host analyst beginning at approximately 9:00 a.m. EDT. A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at A replay of the webcast will be accessible at beginning approximately one hour following the completion of the event.

About Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit and connect on Twitter and Facebook.




Kate Haranis   

Susie Lisa, CFA  

508-683-6585 (office)      

508- 683-5565 (office)   

Media Relations                

Investor Relations  

Boston Scientific Corporation   

Boston Scientific Corporation     

Editor's Details

Mike Wood

Last updated on: 31/07/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.